Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Capsules
Reexamination Certificate
2003-12-18
2009-02-03
Kennedy, Sharon E. (Department: 1615)
Drug, bio-affecting and body treating compositions
Preparations characterized by special physical form
Capsules
C424S408000
Reexamination Certificate
active
07485322
ABSTRACT:
The present invention relates to a novel modified release pharmaceutical composition comprising the coated capsule body, coated or uncoated capsule cap, at least one tablet and granulate comprising active substance.
REFERENCES:
patent: 1815902 (1931-07-01), Ellzey
patent: 2340037 (1944-01-01), Zipper
patent: 3186910 (1965-06-01), Glassman
patent: 3976764 (1976-08-01), Watanabe et al.
patent: 4140755 (1979-02-01), Sheth et al.
patent: 4601896 (1986-07-01), Nugent
patent: 4681583 (1987-07-01), Urquhart et al.
patent: 4814178 (1989-03-01), Bolton et al.
patent: 5002772 (1991-03-01), Curatolo et al.
patent: 5169638 (1992-12-01), Dennis et al.
patent: 5223265 (1993-06-01), Wong
patent: 5232704 (1993-08-01), Franz et al.
patent: 5314696 (1994-05-01), Paulos
patent: 5387421 (1995-02-01), Amidon et al.
patent: 6015577 (2000-01-01), Eisert
patent: 7163693 (2007-01-01), Clarke et al.
patent: 2001/0036473 (2001-11-01), Scott et al.
patent: 2003/0194430 (2003-10-01), Miller et al.
patent: 0714656 (1996-06-01), None
patent: WO98/50019 (1998-11-01), None
patent: WO02/070021 (2002-09-01), None
K H Bauer, K-L Fromming, C Fuhrer: “Lehrbuch der Pharmazeutischen Technologie”, 1999, Wissenschaftliche Verlagsgesellschaft, Stuttgart, XP002278625, p. 340; figure 14.41.
Kennedy Sharon E.
Lek Pharmaceuticals d.d.
Luedeka Neely & Graham P.C.
LandOfFree
Modified release pharmaceutical composition does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Modified release pharmaceutical composition, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Modified release pharmaceutical composition will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-4098108